Effect and Mechanism of Mitomycin C Combined with Recombinant Adeno-Associated Virus Type II against Glioma

The effect of chemotherapy drug Mitomycin C (MMC) in combination with recombinant adeno-associated virus II (rAAV2) in cancer therapy was investigated, and the mechanism of MMC affecting rAAV2’s bioactivity was also studied. The combination effect was evaluated by the level of GFP and TNF expression...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Hong, Zhang, Yunjia, Wang, Hailong, Han, Chuanhui, Lei, Runhong, Zhang, Lei, Yang, Zuye, Rao, Ling, Qing, Hong, Xiang, Jim, Deng, Yulin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3907794/
https://www.ncbi.nlm.nih.gov/pubmed/24451124
http://dx.doi.org/10.3390/ijms15010001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3907794/
https://www.ncbi.nlm.nih.gov/pubmed/24451124
http://dx.doi.org/10.3390/ijms15010001

Ejemplares similares